Taxonomy
PSA on Charcot-Marie-Tooth Disease
The CMTA is thrilled to announce the release of our latest professionally produced Public Service Announcement on Charcot-Marie-Tooth! Watch this beautiful piece and share it with your friends and family to spread the word.NYSCF and CMTA Announce Largest-Ever Research Resource for Neuropathy Disorders
The NYSCF Research Institute and the CMTA announced that the stem cell lines resulting from a collaboration that began in 2014 will now be available for use by other researchers in the largest and first-ever initiative of its kind.New Mobile App Simplifies Sign-Up for Patient Registry
A new mobile app developed by the Rare Diseases Clinical Research Network (RDCRN) makes it easier than ever for CMT patients to sign up for and navigate the network’s patient registry, which will play a key role in identifying patients for clinical trials.New CEO Takes Helm of the CMTA
The CMTA Board of Directors announced May 15 the appointment of Amy J. Gray as the new chief executive officer of the Charcot-Marie-Tooth Association. MDA and CMTA Partner to Advance Treatments and Care for Charcot-Marie-Tooth Disease
The MDA and the CMTA have formed a partnership aimed at advancing CMT research, therapy development and clinical care, while also increasing awareness and understanding of CMT by improving education for patients, medical professionals and the public.MDA and CMTA Fund Grant to Study Gene Therapy in Charcot-Marie-Tooth Disease
The MDA and the CMTA today announced a research grant totaling $119,999 to Kleopas Kleopa, MD, for a study on the effectiveness of a gene therapy approach in the second most common form of Charcot-Marie-Tooth disease (CMT). Invitae Announces Major Expansion of Its Neurology Test Offerings
Invitae Corporation, a genetic information company, today announced it has expanded its neurology test offering, adding 11 new panels for heritable diseases and updating 17 existing neurology panels based on new discoveries in genetics research.Important Alert: Neurotoxic Medication List Update
Dr. Louis Weimer of Columbia University recently updated the CMTA's neurotoxic medication list as part of his review for an upcoming issue of Current Neurology and Neuroscience Reports.How Balance Walking Can Help Fitness and Living with CMT
When living with a condition that can add challenges to starting or maintaining a fitness program. One tool that can help is Balance Walking with Nordic walking poles—a great way to not only get and stay fit, but to make getting around much easier overall.Gilles Bouchard Takes Helm of CMTA Board
Gilles Bouchard took the helm of the Charcot-Marie-Tooth Association March 16, saying that while he is “excited and delighted” with the progress made by the CMTA’s STAR research program, there’s still much work to be done.
